Skip to content
Intrinsic value · Buy/Sell verdict · scores — free· 1403 Nifty 500 stocks· EOD 2026-06-19

JHS Svendgaard Laboratories Limited

JHS · NSE · Consumer Defensive

₹7.99
-0.18 (-2.20%)
Fair valueSell
The bottom line

StocksWizard rates JHS Svendgaard Laboratories Limited a Sell, scoring 40/100 on our blended model. At ₹7.99 it trades below our blended DCF and relative-multiples fair value of ₹15.98, implying roughly 100% upside to that estimate — we read the stock as undervalued by 100%. Financial health scores 16/100 (grade F), in the distress band on the Altman Z-score, with a Piotroski F-score of 1/9. It clears 5 of 12 investability checks, with durability 29, valuation 50 and momentum 14 on our 0–100 scales.

These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.

Our verdictSolvency risk
Sell40/100
Quality29
Valuation75
Momentum14
Financial trend100
Intrinsic value
Our fair value
₹15.98
Undervalued by 100%
Price ₹7.99Range ₹13.92₹17.26

With a 20% margin of safety, our buy-below price is ₹12.78. Low-confidence estimate — limited data.

F
Financial health 16/100
Altman Z 1.63 · Distress zone

Piotroski F-score 1/9 — quality of earnings & balance sheet.

Investability checklist

Passed 5 of 12 checks42/100
  • ROE above 15%-1.1%
  • Low debt (D/E < 0.5)0.09x
  • Positive free cash flow
  • Revenue growth > 10%39%
  • Earnings growing
  • Net margin ≥ 10%-1.8%
  • Current ratio > 1.51.95
  • Below our fair value
  • Margin of safety ≥ 20%
  • Above 200-day average
  • Above 50-day average
  • Positive 1-year return
  • Altman Z in safe zoneZ 1.63
  • Piotroski ≥ 71/9

1-year price

EOD · 2026-06-19
1W
-1.5%
1M
-4.5%
3M
-2.6%
6M
-21.0%
1Y

Our scores

Durability29
Valuation50
Momentum14

Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.

Quarterly results

3Q2017₹31 Cr revenue
Net profit ₹2 Cr6% margin
4Q2017₹44 Cr revenue
Net profit ₹3 Cr6% margin
Revenue Net profitLatest revenue QoQ +40%

Shareholding

Promoter51.0%
Institutions0.0%
Public & other49.0%

Promoter holding via insider stake; institutional via reported holdings.

Key fundamentals

Market cap
₹70 Cr
P/E ratio
P/B ratio
0.40
EPS (TTM)
₹-0.22
ROE
-1.1%
Debt / Equity
0.09x
Profit margin
-1.8%
Free cash flow
₹-8 Cr
52-week high
₹13.56
-41.08% from high
52-week low
₹6.55
Dividend yield
Beta
0.51

SWOT snapshot

Strengths

  • Lightly leveraged balance sheet.

Weaknesses

  • Low return on equity (-1.1%).
  • Price below its 200-day moving average (downtrend).
  • Weak Piotroski score (1/9).

Opportunities

  • Revenue growing (39% YoY).
  • Well off its 52-week high — possible mean-reversion.
  • Trades ~100% below our estimated fair value.

Threats

  • Balance-sheet stress — Altman Z 1.63.

About JHS Svendgaard Laboratories Limited

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, whitening gels, talcum powders, sanitizers, detergents, and denture tablets. It also provides contract manufacturing services for oral care products

More in Consumer Defensive

All stocks

Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.